Relationship between MCP-1 promoter -2518 A/G gene polymorphism (rs1024611) and systemic lupus erythematosus/lupus nephritis

References

• Lee J, Shin EK, Lee SY, et al. Estrogen upregulates IL-21 production by CD4+ T lymphocytes in patients with systemic lupus erythematosus. Immunology 2014. (Epub ahead of print)
   Web of Science ®Google Scholar
• Touma Z, Gladman DD, Urowitz MB, et al. Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis. J Rheumatol 2011;38:69–78
   PubMed Web of Science ®Google Scholar
• Lin LH, Ling P, Liu MF. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus. J Rheumatol 2011;38:1914–9
   PubMed Web of Science ®Google Scholar
• Wang CM, Chang SW, Wu YJ, et al. Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep 2014;4:3792
   PubMed Web of Science ®Google Scholar
• Freedman BI, Langefeld CD, Andringa KK, et al. End-stage renal disease in african americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 2014;66:390–6
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Choi SJ, et al. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011;38:3643–51
   PubMed Web of Science ®Google Scholar
• Kim SK, Choe JY, Bae J, et al. TNFAIP3 gene polymorphisms associated with differential susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Korean population. Rheumatology (Oxford) 2014 . (Epub ahead of print)
   Google Scholar
• Laska MJ, Troldborg A, Hansen B, et al. Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females. Rheumatology (Oxford) 2014;53:48–55
   PubMed Web of Science ®Google Scholar
• Shojaa M, Aghaie M, Amoli M, et al. Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients. Int J Rheum Dis 2014. (Epub ahead of print)
   PubMed Web of Science ®Google Scholar
• Bolin K, Sandling JK, Zickert A, et al. Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS One 2013;8:e84450
   PubMed Web of Science ®Google Scholar
• Caster DJ, Korte EA, Nanda SK, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol 2013;24:1743–54
   PubMed Web of Science ®Google Scholar
• Martens HA, Nienhuis HL, Gross S, et al. Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis. Lupus 2012;21:959–68
   PubMed Web of Science ®Google Scholar
• Gupta M, Chaturvedi R, Jain A. Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine 2013;61:892–7
   PubMed Web of Science ®Google Scholar
• Tofik R, Ohlsson S, Bakoush O. Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study. PLoS One 2014;9:e87857
   PubMed Web of Science ®Google Scholar
• Pola R, Flex A, Gaetani E, et al. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004;39:1249–52
   PubMed Web of Science ®Google Scholar
• Steinmetz OM, Panzer U, Harendza S, et al. No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 2004;19:596–601
   PubMed Web of Science ®Google Scholar
• Abujam B, Cheekatla S, Aggarwal A. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus 2013;22:614–23
   PubMed Web of Science ®Google Scholar
• Barbado J, Martin D, Vega L, et al. MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus. Cytokine 2012;60:583–6
   PubMed Web of Science ®Google Scholar
• Singh RG, Usha, Rathore SS, et al. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 2012;21:1214–8
   PubMed Web of Science ®Google Scholar
• Lee YH, Woo JH, Choi SJ, et al. Functional monocyte chemoattractant protein-1 promoter -2518 polymorphism and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2010;37:3421–6
   PubMed Web of Science ®Google Scholar
• Liu T, Zhai JX, Wang HY, et al. Meta-analysis of MCP-1 promoter -2518 A/G polymorphism and SLE susceptibility. Mol Biol Rep 2012;39:8475–82
   PubMed Web of Science ®Google Scholar
• Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, et al. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001;58:335–8
   PubMedGoogle Scholar
• Hwang SY, Cho ML, Park B, et al. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet 2002;29:413–6
   PubMedGoogle Scholar
• Kim HL, Lee DS, Yang SH, et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002;40:1146–52
   PubMed Web of Science ®Google Scholar
• Liao CH, Yao TC, Chung HT, et al. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 2004;31:2062–7
   PubMed Web of Science ®Google Scholar
• Nakashima H, Akahoshi M, Shimizu S, et al. Absence of association between the MCP-1 gene polymorphism and histological phenotype of lupus nephritis. Lupus 2004;13:165–7
   PubMed Web of Science ®Google Scholar
• Tucci M, Barnes EV, Sobel ES, et al. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004;50:1842–9
   PubMed Web of Science ®Google Scholar
• Ye DQ, Hu YS, Li XP, et al. The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese. Arch Dermatol Res 2005;296:366–71
   PubMed Web of Science ®Google Scholar
• Sanchez E, Sabio JM, Callejas JL, et al. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus. BMC Med Genet 2006;7:48
   PubMed Web of Science ®Google Scholar
• Brown KS, Nackos E, Morthala S, et al. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 2007;34:740–6
   PubMed Web of Science ®Google Scholar
• Lima G, Soto-Vega E, Atisha-Fregoso Y, et al. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Hum Immunol 2007;68:980–5
   PubMed Web of Science ®Google Scholar
• Hoshi D, Okamoto H, Kaneko H, et al. Association of a polymorphism in the monocyte chemoattractant protein-1/CCL2 gene and lupus nephritis in systemic lupus erythematosus patients. Clin Exp Rheumatol 2008;26:972–3
   PubMed Web of Science ®Google Scholar
• Malafronte P, Vieira JM Jr., Pereira AC, et al. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. J Rheumatol 2010;37:776–82
   PubMed Web of Science ®Google Scholar
• Piotrowski P, Lianeri M, Gasik R, et al. Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE. J Biomed Biotechnol 2010;2010:130265
   PubMedGoogle Scholar
• Aranda F, Wingeyer SP, Munoz SA, et al. The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study. Eur Cytokine Netw 2012;23:7–11
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng D, Mao C, et al. Study on the association between MCP-1-2518 promoter polymorphism and systemic lupus erythematosus in Chinese Han in Yunnan Province. Int J Immunol 2007;30:5–8
   Google Scholar
• Wu S, Li F, Wang J, et al. The study of a polymorphism in the monocyte chemoattractant protein-1 promoter gene with lupus nephritis. J Taishan Med Coll 2012;33:241–3
   Google Scholar
• Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail 2013;35:573–8
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Huang JJ, et al. Relationship between the prohibitin 3' untranslated region C > T gene polymorphism and cancer susceptibility–results of a meta-analysis. Asian Pac J Cancer Prev 2012;13:3319–23
   PubMedGoogle Scholar
• Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Liang R. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst 2013;14:235–41
   PubMed Web of Science ®Google Scholar
• Zhou TB, Liu YG, Lin N, et al. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 2012;39:686–93
   PubMed Web of Science ®Google Scholar